or
forgot password
  • cancer clinical trials in ann arbor, MI

  • 24 Months of Exemestane or Letrozole to Treat Breast Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Breast Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Colorectal Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Leukemia
    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lymphoma
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Neuroblastoma
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Melanoma
    Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Pain, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Prostate Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Anemia, Aplastic
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Ann Arbor, Michigan 48106
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Cervical Cancer, Endometrial Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    Veterans Affairs Medical Center - Ann Arbor
    Prostate Cancer
    Molecular Mechanisms and Diagnosis of Mastocytosis
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Mastocytosis
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lung Cancer
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Leukemia
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer
    Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Fallopian Tube Cancer, Female Reproductive Cancer, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Ovarian Epithelial Cancer, Recurrent Uterine Sarcoma, Stage III Ovarian Epithelial Cancer, Stage III Uterine Sarcoma, Stage IV Ovarian Epithelial Cancer, Stage IV Uterine Sarcoma, Uterine Carcinosarcoma, Uterine Leiomyosarcoma
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Bladder Cancer
    A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Postmenopausal Bone Loss, Breast Cancer
    A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
    University of Michigan, Department of Surgery, Pediatric Section
    Ann Arbor, Michigan 48170
    Sarcoma, Neuroblastoma, Wilm's Tumor